Apexigen- Warrants (29/07/2027) Operating Income

As of the most recent data (June 2023), APGNW shows a operating income of $-28M. That compares with $-1.8B in the prior-year period — up 98.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APGNW's operating income is now $-28M (was $-1.8B) — a 98.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Apexigen- Warrants (29/07/2027) is outperforming or lagging.

Tracking APGNW's operating income over time shows whether Apexigen- Warrants (29/07/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $-28M That compares with $-1.8B in the prior-year period — up 98.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Apexigen- Warrants (29/07/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-28M) with ownership activity and broader fundamentals.